Expert Scientific Advisory Committee (ESAC)
MMV’s Expert Scientific Advisory Committee (ESAC) helps to identify the best projects worthy of inclusion in the portfolio and continues to monitor progress through an annual review of all projects. This committee consists of experts from both industry and academia and covers the full range of expertise required to assess projects that are engaging in the extremely complex process of drug research and development.
ESAC Members
Dr Salim Abdullah Director, Ifakara Health Institute, Tanzania
Dr Simon Campbell Chemist, former Senior Vice President, Worldwide Discovery and Medicinal R&D, Europe, Pfizer; (founding Chairman of ESAC from 1999–2003)
Prof Kelly Chibale Founder and Director, University of Cape Town, Drug Discovery and Development Centre (H3-D), South Africa
Dr Robert Clay Vice President Regulatory Affairs, Oncology and Infection, Astra Zeneca, UK
Prof Simon Croft Professor of Parasitology and Head of the Department of Infectious and Tropical Diseases, LSHTM, UK
Dr Umberto D'Alessandro Theme Leader Disease Control and Elimination, Medical Research Council, The Gambia
Prof Ogobara Doumbo Director, Malaria Research and Training Center, Bamako, Mali
Dr R. Kip Guy Department of Chemical Biology and Therapeutics, St Jude Children’s Research Hospital, CA, USA
Dr Kasturi Haldar Professor, Julius Nieuwland Chair of Biological Sciences, Director, Center for Rare and Neglected Diseases, University of Notre Dame, USA
Dr Tran Tinh Hien Deputy Director, Hospital for Tropical Diseases, Ho Chi Minh City, Vietnam
Dr Trevor Laird Managing Director/Owner, Scientific Update, UK
Dr Michael Makanga Director South-South Cooperation and Head of Africa Office, European and Developing Countries Clinical Trials Partnership, South Africa
Dr Christine Manyando, Head of Public Health Department, Tropical Diseases Research Centre, Ndola, Zambia
Dr David McGibney Pharmaceutical Research and Development Expert; Consultant Pharmaceutical Physician; and Co-Chairman MMV ESAC (Development)
Dr George K Mooney KGM Pharma Consulting LLC, USA
Prof François Nosten MD; Director, Shoklo Malaria Research Unit; and part of the Wellcome Trust–Mahidol–Oxford University Tropical Medicine Research Programme, Thailand
Dr Bernhards Ogutu Researcher, Kenya Medical Research Institute, Kenya
Dr Paul Reider, Pharmaceutical Specialist and Lecturer, Department of Chemistry, Princeton Universtiy, NJ, USA
Dr David Roberts Independent Scientific Consultant, Congleton, UK
Dr Dennis Schmatz former Vice President, Head of Tsukuba Research Institute, Merck-Banyu Research Laboratories, Japan; and Co-Chairman MMV ESAC (Discovery)
Dr Peter Siegl Director, Siegl Pharma Consulting LLC, PA, USA
Dr Per Sjoberg Partner, Eureda, Sweden
Prof Dennis Smith former Vice President, PGRD, Pfizer, Kent, UK
Prof Terrie Taylor MD and Distinguished Professor, University of Michigan, MI, USA
Dr Neena Valecha MD and Senior Deputy Director, National Institute of Malaria Research, New Delhi, India
Prof Steve Ward Walter Myers Professor of Parasitology, Liverpool School of Tropical Medicine, UK
Dr Thomas Wellems Chief, Laboratory of Malaria and Vector Research (LMVR), National Institute of Allergy and Infectious Diseases, USA
Dr Mike Witty Chairman, Global Alliance for Livestock Veterinary Medicines, UK
Dr Matthew Wyvratt Senior Vice President, Drug Discovery, Motif BioSciences, Inc., New York, USA